{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:55:09Z","timestamp":1777521309510,"version":"3.51.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007409","name":"Chengde Medical University","doi-asserted-by":"publisher","award":["2024017"],"award-info":[{"award-number":["2024017"]}],"id":[{"id":"10.13039\/501100007409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04525-y","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:40:05Z","timestamp":1745991605000},"page":"3583-3594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of druggable genetic targets for prostate cancer risk based on mendelian randomization and single-cell RNA sequencing"],"prefix":"10.1007","volume":"57","author":[{"given":"Liantai","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cancan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiameng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"1","key":"4525_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"4525_CR2","unstructured":"Ng KL. The etiology of prostate cancer. In: Bott SRJ, Ng KL, editors. Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021 May 27. Chapter 2. PMID: 34181375."},{"key":"4525_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2435-y","author":"R Huang","year":"2020","unstructured":"Huang R et al (2020) CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating \u03b2-catenin\/STAT3 signaling. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-020-2435-y","journal-title":"Cell Death Dis"},{"key":"4525_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215709","volume":"538","author":"A Papachristodoulou","year":"2022","unstructured":"Papachristodoulou A, Abate-Shen C (2022) Precision intervention for prostate cancer: re-evaluating who is at risk. Cancer Lett 538:215709. https:\/\/doi.org\/10.1016\/j.canlet.2022.215709","journal-title":"Cancer Lett"},{"key":"4525_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175730","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M et al (2022) Prostate cancer review: genetics diagnosis treatment options and alternative approaches. Molecules. https:\/\/doi.org\/10.3390\/molecules27175730","journal-title":"Molecules"},{"key":"4525_CR6","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_150_23","author":"AM Alzahrani","year":"2024","unstructured":"Alzahrani AM, Al Shamsi H, Al Momen M, Al Fluij A, Al MA (2024) Prevalence of preexisting cardiovascular diseases in prostate cancer patients and cardiac risks of hormonal therapy. Saudi J Med Med Sci. https:\/\/doi.org\/10.4103\/sjmms.sjmms_150_23","journal-title":"Saudi J Med Med Sci."},{"issue":"3","key":"4525_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pharmthera.2013.07.003","volume":"140","author":"AA Shafi","year":"2013","unstructured":"Shafi AA, Yen AE, Weigel NL (2013) Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Pharmacol Ther 140(3):223\u2013238. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.07.003. (Epub 2013 Jul 13 PMID: 23859952)","journal-title":"Pharmacol Ther"},{"issue":"8","key":"4525_CR8","first-page":"3847","volume":"36","author":"AA Sinha","year":"2016","unstructured":"Sinha AA, Pomroy FE Jr, Wilson MJ (2016) Concurrent androgen and estrogen ablation and inhibition of steroid biosynthetic enzyme treatment for castration-resistant prostate cancer. Anticancer Res 36(8):3847\u20133854 (PMID: 27466486)","journal-title":"Anticancer Res"},{"issue":"24","key":"4525_CR9","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.2174\/0929867329666211221112312","volume":"29","author":"TK Upadhyay","year":"2022","unstructured":"Upadhyay TK, Ali MI, Khan F et al (2022) Nanoparticles mediated target-specific drug delivery in prostate cancer: an in-depth review. Curr Med Chem 29(24):4170\u20134184. https:\/\/doi.org\/10.2174\/0929867329666211221112312. (PMID: 34939536)","journal-title":"Curr Med Chem"},{"key":"4525_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/17407745231207970","author":"V Staedtke","year":"2023","unstructured":"Staedtke V, Anstett K, Bedwell D et al (2023) Gene-targeted therapy for neurofibromatosis and schwannomatosis: the path to clinical trials. Clin Trials. https:\/\/doi.org\/10.1177\/17407745231207970","journal-title":"Clin Trials"},{"issue":"2","key":"4525_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4251\/wjgo.v16.i2.287","volume":"16","author":"F Cao","year":"2024","unstructured":"Cao F, Zhang HL, Guo C, Xu XL, Yuan Q (2024) Targeting oxidative stress with natural products: A novel strategy for esophageal cancer therapy. World J Gastrointest Oncol 16(2):287\u2013299. https:\/\/doi.org\/10.4251\/wjgo.v16.i2.287","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"4525_CR12","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/s41467-021-22444-1","volume":"12","author":"MH Larson","year":"2021","unstructured":"Larson MH, Pan W, Kim HJ et al (2021) A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection. Nat Commun 12(1):2357. https:\/\/doi.org\/10.1038\/s41467-021-22444-1","journal-title":"Nat Commun"},{"issue":"7969","key":"4525_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-023-06225-y","volume":"619","author":"SA Cohen","year":"2023","unstructured":"Cohen SA, Liu MC, Aleshin A (2023) Practical recommendations for using ctDNA in clinical decision making. Nature 619(7969):259\u2013268. https:\/\/doi.org\/10.1038\/s41586-023-06225-y. (Epub 2023 Jul 12 PMID: 37438589)","journal-title":"Nature"},{"key":"4525_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2023.05.003","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhao H (2023) eQTL studies: from bulk tissues to single cells. J Genet Genomics. https:\/\/doi.org\/10.1016\/j.jgg.2023.05.003","journal-title":"J Genet Genomics"},{"key":"4525_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-0716-0026-9_3","volume":"2082","author":"E Mariella","year":"2020","unstructured":"Mariella E, Grassi E, Provero P (2020) eQTL mapping using transcription factor affinity. Methods Mol Biol 2082:39\u201349. https:\/\/doi.org\/10.1007\/978-1-0716-0026-9_3. (PMID: 31849006)","journal-title":"Methods Mol Biol"},{"issue":"13","key":"4525_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.908831","volume":"6","author":"N Gao","year":"2022","unstructured":"Gao N, Kong M, Li X et al (2022) Systemic lupus erythematosus and cardiovascular disease: a mendelian randomization study. Front Immunol 6(13):908831. https:\/\/doi.org\/10.3389\/fimmu.2022.908831","journal-title":"Front Immunol"},{"issue":"1","key":"4525_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","volume":"23","author":"C Wang","year":"2023","unstructured":"Wang C, Zhu D, Zhang D et al (2023) Causal role of immune cells in schizophrenia: mendelian randomization (MR) study. BMC Psychiatry 23(1):590. https:\/\/doi.org\/10.1186\/s12888-023-05081-4","journal-title":"BMC Psychiatry"},{"issue":"1","key":"4525_CR18","doi-asserted-by":"publisher","first-page":"12976","DOI":"10.1038\/s41598-022-17207-x","volume":"12","author":"B Zhang","year":"2022","unstructured":"Zhang B, Huang X, Wang X et al (2022) Using a two-sample mendelian randomization analysis to explore the relationship between physical activity and Alzheimer\u2019s disease. Sci Rep 12(1):12976. https:\/\/doi.org\/10.1038\/s41598-022-17207-x","journal-title":"Sci Rep"},{"issue":"1","key":"4525_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12916-020-01797-2","volume":"18","author":"M Escala-Garcia","year":"2020","unstructured":"Escala-Garcia M, Morra A, Canisius S et al (2020) Breast cancer risk factors and their effects on survival: a Mendelian randomisation study. BMC Med 18(1):327. https:\/\/doi.org\/10.1186\/s12916-020-01797-2","journal-title":"BMC Med"},{"key":"4525_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1084","author":"SL Freshour","year":"2021","unstructured":"Freshour SL, Kiwala S, Cotto KC et al (2021) Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkaa1084","journal-title":"Nucleic Acids Res"},{"key":"4525_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1166","author":"C Finan","year":"2017","unstructured":"Finan C et al (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166","journal-title":"Sci Transl Med"},{"key":"4525_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331142","author":"WM Su","year":"2023","unstructured":"Su WM, Gu XJ, Dou M et al (2023) Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2023-331142","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4525_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00913-z","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ et al (2021) Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. https:\/\/doi.org\/10.1038\/s41588-021-00913-z","journal-title":"Nat Genet"},{"key":"4525_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0142-8","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI et al (2018) Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. https:\/\/doi.org\/10.1038\/s41588-018-0142-8","journal-title":"Nat Genet"},{"issue":"1","key":"4525_CR25","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1038\/s41467-020-18246-6","volume":"11","author":"SR Rashkin","year":"2020","unstructured":"Rashkin SR, Graff RE, Kachuri L et al (2020) Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun 11(1):4423. https:\/\/doi.org\/10.1038\/s41467-020-18246-6","journal-title":"Nat Commun"},{"issue":"362","key":"4525_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"12","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey SG (2018) Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 12(362):k601. https:\/\/doi.org\/10.1136\/bmj.k601","journal-title":"BMJ"},{"key":"4525_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG (2011) CRP CHD genetics collaboration avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol. https:\/\/doi.org\/10.1093\/ije\/dyr036","journal-title":"Int J Epidemiol"},{"key":"4525_CR28","doi-asserted-by":"publisher","unstructured":"1000 Genomes Project Consortium; Abecasis GR, Auton A, et al. 2012. An integrated map of genetic variation from 1,092 human genomes. Nature. https:\/\/doi.org\/10.1038\/nature11632","DOI":"10.1038\/nature11632"},{"issue":"7","key":"4525_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408.PMID:29846171;PMCID:PMC5976434","volume":"30","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 30(7):e34408. https:\/\/doi.org\/10.7554\/eLife.34408.PMID:29846171;PMCID:PMC5976434","journal-title":"Elife"},{"key":"4525_CR30","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15555.3","author":"S Burgess","year":"2023","unstructured":"Burgess S, Davey Smith G, Davies NM et al (2023) Guidelines for performing Mendelian randomization investigations: update for summer. Wellcome Open Res. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3","journal-title":"Wellcome Open Res"},{"issue":"2","key":"4525_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5.PMID:37325194;PMCID:PMC7614635","volume":"10","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV et al (2022) Mendelian randomization. Nat Rev Methods Primers 10(2):6. https:\/\/doi.org\/10.1038\/s43586-021-00092-5.PMID:37325194;PMCID:PMC7614635","journal-title":"Nat Rev Methods Primers"},{"issue":"4","key":"4525_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC et al (2016) Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"key":"4525_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J Epidemiol"},{"issue":"21","key":"4525_CR34","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MFD Greco","year":"2015","unstructured":"Greco MFD, Minelli C, Sheehan NA et al (2015) Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 34(21):2926\u20132940. https:\/\/doi.org\/10.1002\/sim.6522. (Epub 2015 May 7 PMID: 25950993)","journal-title":"Stat Med"},{"issue":"5","key":"4525_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383.PMID:24830394;PMCID:PMC4022491","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10(5):e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383.PMID:24830394;PMCID:PMC4022491","journal-title":"PLoS Genet"},{"issue":"1","key":"4525_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Zhu G, Yang Y et al (2021) Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol 23(1):87\u201398. https:\/\/doi.org\/10.1038\/s41556-020-00613-6. (Epub 2021 Jan 8 PMID: 33420488)","journal-title":"Nat Cell Biol"},{"key":"4525_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4096","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P et al (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. https:\/\/doi.org\/10.1038\/nbt.4096","journal-title":"Nat Biotechnol"},{"issue":"7","key":"4525_CR38","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P et al (2019) Comprehensive integration of single-cell data. Cell 177(7):1888-1902.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031","journal-title":"Cell"},{"issue":"2","key":"4525_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L et al (2019) Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 20(2):163\u2013172. https:\/\/doi.org\/10.1038\/s41590-018-0276-y","journal-title":"Nat Immunol"},{"issue":"7877","key":"4525_CR40","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang Q, Dhindsa RS, Carss K et al (2021) Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature 597(7877):527\u2013532. https:\/\/doi.org\/10.1038\/s41586-021-03855-y","journal-title":"Nature"},{"issue":"R2","key":"4525_CR41","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163.PMID:29771313;PMCID:PMC6061876","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani G, Bowden J, Davey SG (2018) Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet 27(R2):R195\u2013R208. https:\/\/doi.org\/10.1093\/hmg\/ddy163.PMID:29771313;PMCID:PMC6061876","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4525_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2IF:39.1Q1","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre K, McCarthy MI, Schwenk JM (2021) Genetics meets proteomics: perspectives for large population-based studies. Nat Rev Genet 22(1):19\u201337. https:\/\/doi.org\/10.1038\/s41576-020-0268-2IF:39.1Q1. (Epub 2020 Aug 28 PMID: 32860016)","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4525_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jama.2021.20356.PMID:34982132;PMCID:PMC8880207","volume":"327","author":"L Bastarache","year":"2022","unstructured":"Bastarache L, Denny JC, Roden DM (2022) Phenome-wide association studies. JAMA 327(1):75\u201376. https:\/\/doi.org\/10.1001\/jama.2021.20356.PMID:34982132;PMCID:PMC8880207","journal-title":"JAMA"},{"issue":"3","key":"4525_CR44","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/cells12030512.PMID:36766853;PMCID:PMC9914165","volume":"12","author":"K Voskarides","year":"2023","unstructured":"Voskarides K, Giannopoulou N (2023) The role of TP53 in adaptation and evolution. Cells 12(3):512. https:\/\/doi.org\/10.3390\/cells12030512.PMID:36766853;PMCID:PMC9914165","journal-title":"Cells"},{"issue":"3","key":"4525_CR45","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/biom10030420.PMID:32182711;PMCID:PMC7175209","volume":"10","author":"M Mijit","year":"2020","unstructured":"Mijit M, Caracciolo V, Melillo A, Amicarelli F, Giordano A (2020) Role of p53 in the regulation of cellular senescence. Biomolecules 10(3):420. https:\/\/doi.org\/10.3390\/biom10030420.PMID:32182711;PMCID:PMC7175209","journal-title":"Biomolecules"},{"issue":"1","key":"4525_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey BJ, Kelly GL, Janic A et al (2018) How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ 25(1):104\u2013113. https:\/\/doi.org\/10.1038\/cdd.2017.169","journal-title":"Cell Death Differ"},{"issue":"45","key":"4525_CR47","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1038\/onc.2017.225","volume":"36","author":"D Ashikari","year":"2017","unstructured":"Ashikari D, Takayama K, Tanaka T et al (2017) Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer. Oncogene 36(45):6272\u20136281. https:\/\/doi.org\/10.1038\/onc.2017.225. (Epub 2017 Jul 10 PMID: 28692047)","journal-title":"Oncogene"},{"issue":"12","key":"4525_CR48","first-page":"7195","volume":"11","author":"C Zhu","year":"2019","unstructured":"Zhu C, Kong Z, Wang B et al (2019) ITGB3\/CD61: a hub modulator and target in the tumor microenvironment. Am J Transl Res. 11(12):7195\u20137208","journal-title":"Am J Transl Res."},{"issue":"9","key":"4525_CR49","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.7314\/apjcp.2013.14.9.5281","volume":"14","author":"J Li","year":"2013","unstructured":"Li J, Xu YH, Lu Y et al (2013) Identifying differentially expressed genes and small molecule drugs for prostate cancer by a bioinformatics strategy. Asian Pac J Cancer Prev 14(9):5281\u20135286. https:\/\/doi.org\/10.7314\/apjcp.2013.14.9.5281. (PMID: 24175814)","journal-title":"Asian Pac J Cancer Prev"},{"key":"4525_CR50","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S90998IF","author":"R Ni","year":"2015","unstructured":"Ni R, Huang Y, Wang J (2015) miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer. Onco Targets Ther. https:\/\/doi.org\/10.2147\/OTT.S90998IF","journal-title":"Onco Targets Ther"},{"issue":"17","key":"4525_CR51","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.3390\/ijms21176265","volume":"21","author":"K Singh","year":"2020","unstructured":"Singh K, Jamshidi N, Zomer R, Piva TJ, Mantri N (2020) Cannabinoids and prostate cancer: a systematic review of animal studies. Int J Mol Sci 21(17):6265. https:\/\/doi.org\/10.3390\/ijms21176265","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4525_CR52","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/ijc.23674.","volume":"123","author":"MP Endsley","year":"2008","unstructured":"Endsley MP, Thill R, Choudhry I et al (2008) Expression and function of fatty acid amide hydrolase in prostate cancer. Int J Cancer 123(6):1318\u20131326. https:\/\/doi.org\/10.1002\/ijc.23674.","journal-title":"Int J Cancer"},{"issue":"8","key":"4525_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012275IF","volume":"5","author":"L Thors","year":"2010","unstructured":"Thors L, Bergh A, Persson E et al (2010) Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4. PLoS ONE 5(8):e12275. https:\/\/doi.org\/10.1371\/journal.pone.0012275IF","journal-title":"PLoS ONE"},{"issue":"3","key":"4525_CR54","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/ijms24032862","volume":"24","author":"Y Chen","year":"2023","unstructured":"Chen Y, Huang W, Ouyang J et al (2023) Identification of anoikis-related subgroups and prognosis model in liver hepatocellular carcinoma. Int J Mol Sci 24(3):2862. https:\/\/doi.org\/10.3390\/ijms24032862","journal-title":"Int J Mol Sci"},{"key":"4525_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2021.183716","author":"S Dadsena","year":"2021","unstructured":"Dadsena S, King LE, Garc\u00eda-S\u00e1ez AJ (2021) Apoptosis regulation at the mitochondria membrane level. Biochim Biophys Acta Biomembr. https:\/\/doi.org\/10.1016\/j.bbamem.2021.183716","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"4525_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/bit.28062","author":"MA MacDonald","year":"2022","unstructured":"MacDonald MA, Barry C, Groves T, Mart\u00ednez VS, Gray PP, Baker K, Shave E, Mahler S, Munro T, Marcellin E, Nielsen LK (2022) Modeling apoptosis resistance in CHO cells with CRISPR-mediated knockouts of Bak1, Bax, and Bok. Biotechnol Bioeng. https:\/\/doi.org\/10.1002\/bit.28062","journal-title":"Biotechnol Bioeng"},{"key":"4525_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2009.01.004IF","author":"RW DeVere White","year":"2009","unstructured":"DeVere White RW, Vinall RL, Tepper CG, Shi XB (2009) MicroRNAs and their potential for translation in prostate cancer. Urol Oncol. https:\/\/doi.org\/10.1016\/j.urolonc.2009.01.004IF","journal-title":"Urol Oncol"},{"issue":"11","key":"4525_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fendo.2020.00002","volume":"23","author":"J Qin","year":"2020","unstructured":"Qin J, Yang Y, Zhuang X et al (2020) Association between BAK1 gene rs210138 polymorphisms and testicular germ cell tumors: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 23(11):2. https:\/\/doi.org\/10.3389\/fendo.2020.00002","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"4525_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbt.22749","volume":"35","author":"X Kong","year":"2021","unstructured":"Kong X, Wang JS, Yang H (2021) Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway. J Biochem Mol Toxicol 35(6):1\u201311. https:\/\/doi.org\/10.1002\/jbt.22749. (Epub 2021 Feb 25 PMID: 33634536)","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"4525_CR60","first-page":"1293","volume":"9","author":"S Li","year":"2019","unstructured":"Li S, Dai Z, Yang D et al (2019) Targeting \u03b22 subunit of Na\/K-ATPase induces glioblastoma cell apoptosis through elevation of intracellular Ca. Am J Cancer Res 9(6):1293\u20131308","journal-title":"Am J Cancer Res"},{"key":"4525_CR61","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2022.1025IF","author":"J Li","year":"2023","unstructured":"Li J, Xin Y, Li J et al (2023) Phosphatidylethanolamine N-methyltransferase: from functions to diseases. Aging Dis. https:\/\/doi.org\/10.14336\/AD.2022.1025IF","journal-title":"Aging Dis"},{"issue":"10","key":"4525_CR62","doi-asserted-by":"publisher","first-page":"10986","DOI":"10.1096\/fj.201900679R","volume":"33","author":"S Wan","year":"2019","unstructured":"Wan S, van der Veen JN, Bakala N\u2019Goma JC et al (2019) Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance. FASEB J 33(10):10986\u201310995. https:\/\/doi.org\/10.1096\/fj.201900679R. (Epub 2019 Jul 24 PMID: 31284753)","journal-title":"FASEB J"},{"issue":"16","key":"4525_CR63","doi-asserted-by":"publisher","first-page":"9296","DOI":"10.3390\/ijms23169296","volume":"23","author":"IS Piras","year":"2022","unstructured":"Piras IS, Raju A, Don J et al (2022) Hepatic PEMT expression decreases with increasing NAFLD severity. Int J Mol Sci 23(16):9296. https:\/\/doi.org\/10.3390\/ijms23169296","journal-title":"Int J Mol Sci"},{"key":"4525_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2019.02.001","author":"G Bale","year":"2019","unstructured":"Bale G, Vishnubhotla RV, Mitnala S et al (2019) Whole-exome sequencing identifies a variant in phosphatidylethanolamine N-methyltransferase gene to be associated with lean-nonalcoholic fatty liver disease. J Clin Exp Hepatol. https:\/\/doi.org\/10.1016\/j.jceh.2019.02.001","journal-title":"J Clin Exp Hepatol"},{"issue":"5","key":"4525_CR65","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","volume":"16","author":"JM Banales","year":"2019","unstructured":"Banales JM, Huebert RC, Karlsen T et al (2019) Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol 16(5):269\u2013281. https:\/\/doi.org\/10.1038\/s41575-019-0125-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4525_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdnut.2024.102075IF:4.8","volume":"8","author":"Q He","year":"2024","unstructured":"He Q, Wei Y, Zhu H et al (2024) The mediating effect of the choline-to-betaine ratio on the association between PEMT rs7946 and digestive system cancer: a nested case-control study in a chinese population. Curr Dev Nutr 8(2):102075. https:\/\/doi.org\/10.1016\/j.cdnut.2024.102075IF:4.8","journal-title":"Curr Dev Nutr"},{"issue":"45","key":"4525_CR67","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040299","volume":"103","author":"J Xi","year":"2024","unstructured":"Xi J, Cheng X, Liu J (2024) Causal relationship between gout and liver cancer: a mendelian randomization and transcriptome analysis. Medicine (Baltimore) 103(45):e40299. https:\/\/doi.org\/10.1097\/MD.0000000000040299","journal-title":"Medicine (Baltimore)"},{"issue":"19","key":"4525_CR68","doi-asserted-by":"publisher","first-page":"10745","DOI":"10.3390\/ijms251910745","volume":"25","author":"J Korbecki","year":"2024","unstructured":"Korbecki J, Bosiacki M, Kupnicka P, Barczak K, Zi\u0119tek P, Chlubek D, Baranowska-Bosiacka I (2024) Biochemistry and diseases related to the interconversion of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine. Int J Mol Sci 25(19):10745. https:\/\/doi.org\/10.3390\/ijms251910745","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4525_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13395-023-00327-x","volume":"13","author":"MR Lambert","year":"2023","unstructured":"Lambert MR, Gussoni E (2023) Tropomyosin 3 (TPM3) function in skeletal muscle and in myopathy. Skelet Muscle 13(1):18. https:\/\/doi.org\/10.1186\/s13395-023-00327-x","journal-title":"Skelet Muscle"},{"issue":"9","key":"4525_CR70","doi-asserted-by":"publisher","first-page":"9053","DOI":"10.1007\/s13277-014-1974-1","volume":"35","author":"T Tao","year":"2014","unstructured":"Tao T, Shi Y, Han D et al (2014) TPM3, a strong prognosis predictor, is involved in malignant progression through MMP family members and EMT-like activators in gliomas. Tumour Biol 35(9):9053\u20139059. https:\/\/doi.org\/10.1007\/s13277-014-1974-1. (Epub 2014 Jun 10 PMID: 24913705)","journal-title":"Tumour Biol"},{"key":"4525_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.155814","volume":"266","author":"X Tu","year":"2025","unstructured":"Tu X, Zhu M, Liu Q, Liu X, Qi Y, Zhang Y, Li H, Tao T, Chang J, Zhu J, Mu D, Ren L, Cao D, Li T (2025) Renal cell carcinoma with ALK-TPM3 gene fusion and ALK amplification: a case report and literature review. Pathol Res Pract 266:155814. https:\/\/doi.org\/10.1016\/j.prp.2025.155814. (Epub 2025 Jan 6 PMID: 39813766)","journal-title":"Pathol Res Pract"},{"key":"4525_CR72","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2024.2386915","author":"F Wei","year":"2024","unstructured":"Wei F, Wang Y, Yao J, Mei L, Huang X, Kong H, Chen J, Chen X, Liu L, Wang Z, Wang J, Song J, Kong E, Yang A (2024) ZDHHC7-mediated\u00a0S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. Autophagy. https:\/\/doi.org\/10.1080\/15548627.2024.2386915","journal-title":"Autophagy"},{"issue":"26","key":"4525_CR73","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41388-023-02718-2","volume":"42","author":"Z Lin","year":"2023","unstructured":"Lin Z, Agarwal S, Tan S et al (2023) Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer. Oncogene 42(26):2126\u20132138. https:\/\/doi.org\/10.1038\/s41388-023-02718-2. (Epub 2023 May 17 PMID: 37198397)","journal-title":"Oncogene"},{"issue":"1","key":"4525_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13073-023-01229-9.PMID:37726845;PMCID:PMC10508028","volume":"15","author":"J Sun","year":"2023","unstructured":"Sun J, Zhao J, Jiang F et al (2023) Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome. Genome Med 15(1):75. https:\/\/doi.org\/10.1186\/s13073-023-01229-9.PMID:37726845;PMCID:PMC10508028","journal-title":"Genome Med"},{"key":"4525_CR75","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302394","author":"H Liu","year":"2024","unstructured":"Liu H, Guan L, Su X, Zhao L, Shu Q, Zhang J (2024) A broken network of susceptibility genes in the monocytes of Crohn\u2019s disease patients. Life Sci Alliance. https:\/\/doi.org\/10.26508\/lsa.202302394","journal-title":"Life Sci Alliance"},{"issue":"1","key":"4525_CR76","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1IF:16.6Q1.PMID:34930919;PMCID:PMC8688480","volume":"12","author":"CS Storm","year":"2021","unstructured":"Storm CS, Kia DA, Almramhi MM et al (2021) Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat Commun 12(1):7342. https:\/\/doi.org\/10.1038\/s41467-021-26280-1IF:16.6Q1.PMID:34930919;PMCID:PMC8688480","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1007\/s11255-025-04573-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000}}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04525-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04525-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04525-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:36:25Z","timestamp":1759844185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04525-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":76,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4525"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04525-y","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11255-025-04573-4","asserted-by":"object"}]},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11255-025-04573-4","URL":"https:\/\/doi.org\/10.1007\/s11255-025-04573-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}}]}}